VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...
Mazdutide, a dual glucagon and GLP-1 agonist, delivers greater HbA1c and weight reductions than dulaglutide in people with ...
Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg/m2 or greater –– ...
Janus kinase (JAK) inhibitors, including baricitinib, block cytokine signaling and are effective disease-modifying treatments for several autoimmune diseases. Whether baricitinib preserves β-cell ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Background The global surge in ultra-processed food (UPF) consumption is a major public health challenge, particularly among ...
Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes had a higher time in range with fully closed-loop insulin delivery than with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback